Jounce Therapeutics, Inc. (JNCE)
Q2 2019 Earnings Conference Call
August 07, 2019, 08:00 ET
Company Participants
Komal Joshi - Head, IR & Strategic Finance
Richard Murray - President, CEO & Director
Elizabeth Tréhu - Chief Medical Officer
Kimberlee Drapkin - CFO & Treasurer
Conference Call Participants
Debjit Chattopadhyay - H.C. Wainwright & Co.
Steven Seedhouse - Raymond James & Associates
James Birchenough - Wells Fargo Securities
Michael Ulz - Robert W. Baird & Co.
James Scott - JPMorgan Chase & Co.
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to Jounce Therapeutics Second Quarter